title: Risk factors on graft survival of living donor kidney transplantation.
abstract: Living donors have always been the basic resources of transplantation in our country, where cadaveric harvesting is still hampered for various reasons.
  
  
  OBJECTIVE
  The aim of this study was to compare graft survival rates between living unrelated donor (LURD) and living related donor (LRD), to assess the potential risk factors for the graft survival, and to discuss the role of LURD.
  
  
  METHODS
  From October 1991 to February 2003, 77 living donor renal transplants were performed: 41 were LURD and 36 were LRD transplants. The analyzed variables were donor relationship, recipient age and sex, donor age and sex, HLA-DR mismatching, nonspecific blood transfusion history of donor, acute rejection episodes, repeated rejection episode (more than 3 times), delayed graft function, recurred primary disease, and immunosuppressive regimen. Graft survival rate was assessed with the Kaplan-Meier method and the significance of possible variables with the Cox proportional hazard model.
  
  
  RESULTS
  Eleven recipients lost their grafts (6 from LURD and 5 from LRD), most of them are due to chronic rejection (n = 7). Overall 3-, 5- and 10-year graft survival in live donors were 92.8%, 86.6%, and 76.9%, respectively. Graft survival at 3, 5, and 10 years being 91.9%, 88.5%, and 74.7% for the LURD versus 94%, 84%, and 78.8% for LRD transplants (P > .05). Acute rejection episodes, especially more than 3 times (risk ratio [RR] = 11.1) and preoperative multiple transfusion history (RR = 4.2) were significant factors on graft survival in our series.
  
  
  CONCLUSIONS
  Acute rejection episodes markedly decreased the long-term graft survival in live donor renal transplants. The use of LURD transplants provides graft survival comparable with LRD transplants and proper management to acute rejection is essential for long-term graft survival.
authors.affiliation: Department of Surgery, Gachon Medical School, Gil Medical Center, Inchon, Korea. pyh@ghil.com
authors.forename: Y H
authors.initials: YH
authors.lastname: Park
authors.forename: S K
authors.initials: SK
authors.lastname: Min
authors.forename: J N
authors.initials: JN
authors.lastname: Lee
authors.forename: H H
authors.initials: HH
authors.lastname: Lee
authors.forename: W K
authors.initials: WK
authors.lastname: Jung
authors.forename: J S
authors.initials: JS
authors.lastname: Lee
authors.forename: J H
authors.initials: JH
authors.lastname: Lee
authors.forename: Y D
authors.initials: YD
authors.lastname: Lee
mesh_terms: D000328:Adult; D000368:Aged; D005190:Family; D005260:Female; D006085:Graft Survival / Q000276:immunology / Q000502:physiology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data